American Oncology Network advances karyogram segmentation

American Oncology Network and the AON Central Lab announces the implementation of the new cytogenetics A.I. software HiBand v8.4 for karyogram segmentation and classification. “We are committed to our patients, and our continuous goal with any process is to decrease the time between analysis and results so that our patients not only receive the findings within a reasonable timeframe but can take action quicker alongside their physician,” said Stephen “Fred” Divers, MD, AON’s chief medical officer. “This software supports us in accelerating analysis processing, which means faster diagnosis and treatment plans and improved patient outcomes. Above all, it results in significant efficiency gains for those involved, from our lab technologists to physicians and their patients.”